5th Leonard Berg Symposium
5th Leonard Berg Symposium
Antecedent Biomarkers for Early & Preclinical
Detection of Alzheimer's Disease
October 7-8, 2005
Eric P. Newman Education Center
Sponsored by:
The Charles F. and Joanne Knight Alzheimer's Disease Research Center
Department of Neurology
Washington University School of Medicine
Supported in part by an unrestricted educational grant from Pfizer, Inc.
About the Event:
The 5th Leonard Berg Symposium will take place on October 7-8, 2005, at the Eric P. Newman Education Center on the campus of Washington University School of Medicine. This 2-day conference will review current and emerging findings concerning: (1) Risk factors for Alzheimer's disease (AD) identified in pre-clinical and early clinical stages; (2) Genetic markers for AD development and progression; (3) Preclinical detection of AD though the use of antecedent biomarkers & related neuroimaging techniques.
Target Audience:
Physicians, dementia specialists, neuroscientists, university medical/science faculty, advanced trainees (i.e., graduate students, fellows, medical residents), scientists and professionals from industry, neuropsychologists, and other professional or lay individuals with interests in antecedent biomarkers and/or the early detection of dementing disorders.
Objectives of the Symposium:
-
To review current and emerging findings concerning:
- Risk factors for Alzheimer’s disease (AD) identified in pre-clinical and early clinical stages;
- Genetic markers for AD development and progression;
- Preclinical detection of AD through the use of antecedent biomarkers and related neuroimaging imaging techniques.
Program Schedule:
Friday, October 7, 2005
Session 1: Risk Factors for Preclinical Alzheimer’s Disease |
|
7:30 AM |
Registration Desk Opens & Continental Breakfast (Lobby, EP Newman Education Center) |
8:15 |
Welcome & Opening Remarks |
8:30 |
The Epidemiological Perspective |
9:15 |
Predictors of Alzheimer’s Disease |
10:00 |
Break (beverage & snack) |
10:30 |
Clinical-Cognitive Markers from a Longitudinal Study of Aging & Dementia |
11:15 |
Q & A Panel (Moderator: John C. Morris, MD)
|
11:45 PM |
Buffet Luncheon (Great Rooms A & B) Note: Due to space constraints in the dining area, some attendees from Washington University will be asked to eat in the main auditorium and watch this presentation via close circuit TV. |
Session 2: Genetic Markers of Alzheimer’s Disease |
|
1:15 |
Genetic Factors as Antecedent Markers for Alzheimer’s Disease |
2:00 |
Quantitative Traits in Complex Diseases: The Cardiovascular Disease Perspective |
2:45 |
The Application of Genomic & Proteomic Techniques in Cancer |
| 3:30 | Alzheimer's Biomarker Knowledge Base Project Sherrilynne Fuller, PhD, Professor of Medical Education & Biomedical Informatics, University of Washington |
3:45 |
Break |
Special Session: Celebrating AD Research – Past & Future |
|
4:00 |
The NIA Alzheimer’s Disease Centers Program |
4:20 |
Alzheimer’s Disease Research at Washington University: 20 Years of Teamwork & Discovery |
4:40 |
Personal Reflections on Alzheimer’s Disease Research |
5:00 – 6:30 |
Reception & Poster Session (Lobby) |
7:00 |
Faculty Dinner (Bar Italia, 13 Maryland Plaza, Central West End, St. Louis)
|
Saturday, October 8, 2005
Session 3: Antecedent Biomarkers for Alzheimer’s Disease |
|
| 7:00 AM | Biomarkers Working Group Meeting & Breakfast (closed meeting, by invitation only) |
7:30 |
Registration Desk Opens & Continental Breakfast (Lobby, EP Newman Education Center)
|
8:30 |
Welcome & Opening Remarks |
| 8:40 | Lifestyle Factors and the Search for Antecedent Biomarkers: A Clinician's Perspective Eric B. Larson, MD, MPH, FACP, Professor of Medicine, University of Washington School of Medicine |
9:25 |
Antecedent Biomarkers for AD: Data from Unbiased & Biased Approaches |
10:10 |
BREAK(beverage & snack) |
10:30 |
Identifying Candidate Biomarkers for AD: An Industry Perspective |
11:15 |
NIA Alzheimer’s Disease Neuroimaging Initiative - Biomarkers Program |
12:00 |
Buffet Luncheon (Great Rooms A & B) Note: Due to space constraints in the dining area, some attendees from Washington University will be asked to eat in the main auditorium and watch this presentation via close circuit TV. |
Session 4: Neuroimaging and the Detection of Preclinical Alzheimer’s Disease |
|
1:30 |
Structural & Functional Neuroimaging for Preclinical Detection |
2:15 |
Benzothiazole Amyloid-Imaging Agents |
| 3:00 | PIB Imaging at Washington University Mark Mintun, MD, Professor of Radiology & Psychiatry, WUSM |
3:30 |
Q & A Panel (Moderator: John C. Morris, MD) |
| 4:00 | Closing Remarks & Evaluation |
5:30 |
Faculty Dinner (location TBA) |